B Joelsson
Overview
Explore the profile of B Joelsson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
45
Citations
441
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kahrilas P, Falk G, Johnson D, Schmitt C, Collins D, Whipple J, et al.
Aliment Pharmacol Ther
. 2000 Sep;
14(10):1249-58.
PMID: 11012468
Background: The pharmacologic profile of the new proton pump inhibitor esomeprazole has demonstrated advantages over omeprazole that suggest clinical benefits for patients with acid-related disease. Methods: 1960 patients with endoscopy-confirmed...
2.
Richter J, Peura D, Benjamin S, Joelsson B, Whipple J
Arch Intern Med
. 2000 Jun;
160(12):1810-6.
PMID: 10871975
Background: Up to three quarters of patients with gastroesophageal reflux disease (GERD) have symptoms, such as heartburn, but no macroscopic evidence of erosive esophagitis, making symptomatic GERD a common clinical...
3.
Maton P, Orlando R, Joelsson B
Aliment Pharmacol Ther
. 1999 Jun;
13(6):819-26.
PMID: 10383513
Background: H2-receptor antagonists are widely used in patients with gastro-oesophageal reflux disease (GERD) and are frequently continued when symptoms persist. Aim: To compare the efficacy of omeprazole 20 mg once...
4.
Holzer S, Juday T, Joelsson B, Crawley J
Am J Manag Care
. 1999 May;
4(10):1450-60.
PMID: 10338737
Objective: To design a decision analytic model to help determine the costs associated with various treatment regimens for gastroesophageal reflux disease (GERD). Study Design: A decision analytic model incorporating Markov...
5.
Kahrilas P, Fennerty M, Joelsson B
Am J Gastroenterol
. 1999 Feb;
94(1):92-7.
PMID: 9934737
Objective: H2-receptor antagonists are commonly used as initial therapy in patients with gastroesophageal reflux disease (GERD) and are frequently continued at the same or higher doses when symptoms persist after...
6.
Johnsson F, Roth Y, Damgaard Pedersen N, Joelsson B
Aliment Pharmacol Ther
. 1993 Feb;
7(1):81-6.
PMID: 8439641
A questionnaire was constructed and validated to improve the accuracy of symptom assessment in diagnosing gastro-oesophageal reflux disease (GERD). The GERD questionnaire consisted of four questions describing an upward moving,...
7.
Johansson J, Johnsson F, Joelsson B, Floren C, Walther B
Br J Surg
. 1993 Jan;
80(1):46-9.
PMID: 8428292
Forty patients with a mean age of 45 (range 22-65) years were operated on between 1982 and 1985 for gastro-oesophageal reflux disease with a short floppy 360 degree fundoplication. The...
8.
Joelsson B, Johnsson F
Gut
. 1989 Nov;
30(11):1523-5.
PMID: 2599437
To determine whether symptoms of gastro-oesophageal reflux are related to the degree of oesophageal acid exposure, 190 patients (of 220 referred) with heartburn and acid regurgitation were compared with 50...
9.
Walther B, Zilling T, Johnsson F, Stael von Holstein C, Joelsson B
Br J Surg
. 1989 Sep;
76(9):909-12.
PMID: 2804585
When performing total gastrectomy and oesophagojejunostomy with a circular stapling device two disadvantages are obvious; firstly, a purse-string suture is needed, and secondly the instrument can be extremely difficult to...
10.
Johnsson F, Joelsson B, Gudmundsson K
Br J Surg
. 1989 Mar;
76(3):241-4.
PMID: 2720318
Gastro-oesophageal reflux was measured by 24-h ambulatory oesophageal pH monitoring in 220 patients with symptoms suggestive of gastro-oesophageal reflux disease. By multiple regression analysis it was found that the pressure...